Trials / Terminated
TerminatedNCT05549323
A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis
A PHASE 1B, TWO-PART, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF ORAL PF-07054894 IN ADULT PARTICIPANTS AGED 18-75 YEARS WITH MILD TO SEVERE ULCERATIVE COLITIS
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a study to learn if the experimental medicine (called PF-07054894) is safe, effective, and how it is processed in adult people with ulcers in the colon.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PF-07054894 | Oral |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2022-11-07
- Primary completion
- 2025-11-11
- Completion
- 2025-11-11
- First posted
- 2022-09-22
- Last updated
- 2026-02-25
Locations
17 sites across 3 countries: United States, Germany, Poland
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05549323. Inclusion in this directory is not an endorsement.